Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.2578928009329552e-56,65.59160305343511,8404.27395555878,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.870521282425684e-54,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,6.869520555781741e-23,14.460124712832295,737.9343308133988,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",8.930376722516263e-21,0,0,40
3,Nonalcoholic fatty liver disease WP4396,8.029216806550636e-14,7.58330637334196,228.66022810633768,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS', 'BAX']",6.958654565677218e-12,0,0,32
4,Mitochondrial CIV Assembly WP4922,2.8904750846504165e-10,19.093264248704664,419.37266705835077,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",1.8788088050227708e-08,0,0,15
5,Oxidative phosphorylation WP623,3.226221024168685e-08,7.251644736842105,125.0862977589211,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.6776349325677163e-06,0,0,18
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.1738204643761504e-07,7.633217993079585,121.80960934285743,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'TMEM126B']",5.086555345629986e-06,0,0,16
7,Mitochondrial complex III assembly WP4921,2.2537386633449003e-06,52.79216354344123,686.4522840693254,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",8.371029320995345e-05,0,0,7
8,Cellular Proteostasis WP4918,0.00012345375409439355,37.58064516129032,338.2124252164532,"['VBP1', 'PFDN1', 'PFDN4', 'PFDN5', 'PFDN6']",0.00401224700806779,0,0,5
9,Pyrimidine metabolism WP4022,0.007190692586114049,2.899104320337197,14.306986427916947,"['NT5C', 'POLD4', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.19362534359529704,0,0,10
10,mRNA Processing WP411,0.00752292205122474,4.5081632653061225,22.044019646303845,"['LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SRSF9', 'LSM2']",0.19362534359529704,0,0,6
11,Proteasome Degradation WP183,0.008191841459801029,3.7597955706984667,18.06437607594553,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'HLA-B', 'PSMB10']",0.19362534359529704,0,0,7
12,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.013969164485794255,inf,inf,"['ELOB', 'ELOC']",0.30266523052554223,0,0,2
13,Iron metabolism in placenta WP2007,0.03861288607714894,14.95608108108108,48.66961873618968,"['HEPHL1', 'FTH1']",0.7722577215429788,0,0,2
14,Oxidative Damage WP3941,0.05795293947664832,3.328813559322034,9.480873743636726,"['C1QA', 'CYCS', 'NFKBIE', 'C1QC']",0.9979240165281176,0,0,4
15,Prostaglandin Synthesis and Regulation WP98,0.06476702969861073,2.6764491874848413,7.325330637353937,"['HSD11B2', 'ANXA3', 'TBXAS1', 'AKR1C3', 'S100A6']",0.9979240165281176,0,0,5
16,Dual hijack model of Vif in HIV infection WP3300,0.07121835963085764,7.476351351351352,19.75255491433985,"['ELOB', 'ELOC']",0.9979240165281176,0,0,2
17,Eukaryotic Transcription Initiation WP405,0.10486928250931422,3.2059463379260333,7.2295392588385665,"['POLR2I', 'POLR2J', 'POLR2K']",0.9979240165281176,0,0,3
18,Insulin signaling in adipocytes (diabetic condition) WP3635,0.11827931288193659,inf,inf,['RPS6'],0.9979240165281176,0,0,1
19,Insulin signaling in adipocytes (normal condition) WP3634,0.11827931288193659,inf,inf,['RPS6'],0.9979240165281176,0,0,1
20,Mitochondrial CII Assembly WP4920,0.11827931288193659,inf,inf,['SDHAF1'],0.9979240165281176,0,0,1
21,Base Excision Repair WP4752,0.1320589191709818,2.8045685279187818,5.677868893359285,"['POLD4', 'APEX1', 'POLE3']",0.9979240165281176,0,0,3
22,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.15183908517885497,3.7364864864864864,7.043030303240421,"['EIF3D', 'EIF1']",0.9979240165281176,0,0,2
23,Nucleotide Excision Repair WP4753,0.16137133041902127,2.4923857868020303,4.546229239812301,"['POLD4', 'POLE3', 'GTF2H5']",0.9979240165281176,0,0,3
24,Modulators of TCR signaling and T cell activation WP5072,0.17960520277235234,1.9945762711864408,3.424675799065455,"['ZAP70', 'NDUFB10', 'ELOB', 'RNF7']",0.9979240165281176,0,0,4
25,DNA Repair Pathways Full Network WP4946,0.18648644373448262,1.781469803541111,2.991794563178937,"['POLD4', 'CENPX', 'APEX1', 'POLE3', 'GTF2H5']",0.9979240165281176,0,0,5
26,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.1965824447424786,2.9885135135135137,4.861335346962544,"['H2AFZ', 'HIST1H3E']",0.9979240165281176,0,0,2
27,Gastric Cancer Network 2 WP2363,0.1965824447424786,2.9885135135135137,4.861335346962544,"['S100A6', 'COL9A3']",0.9979240165281176,0,0,2
28,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1965824447424786,2.9885135135135137,4.861335346962544,"['ZAP70', 'HLA-DRB1']",0.9979240165281176,0,0,2
29,MED and Pseudoachondroplasia genes WP4789,0.22258948794367897,7.465430016863406,11.216256645474603,['COL9A3'],0.9979240165281176,0,0,1
30,Peroxiredoxin 2 induced ovarian failure WP4873,0.22258948794367897,7.465430016863406,11.216256645474603,['BAX'],0.9979240165281176,0,0,1
31,Purine metabolism WP4792,0.22258948794367897,7.465430016863406,11.216256645474603,['APRT'],0.9979240165281176,0,0,1
32,Serotonin and anxiety WP3947,0.24262097398023158,2.489864864864865,3.5262831439513307,"['POMC', 'CRH']",0.9979240165281176,0,0,2
33,Cancer immunotherapy by PD-1 blockade WP4585,0.24262097398023158,2.489864864864865,3.5262831439513307,"['ZAP70', 'HLA-DRB1']",0.9979240165281176,0,0,2
34,Complement Activation WP545,0.24262097398023158,2.489864864864865,3.5262831439513307,"['C1QA', 'C1QC']",0.9979240165281176,0,0,2
35,NOTCH1 regulation of endothelial cell calcification WP3413,0.24262097398023158,2.489864864864865,3.5262831439513307,"['SOX6', 'DLL3']",0.9979240165281176,0,0,2
36,Selenium Micronutrient Network WP15,0.24766213302562792,1.4959183673469387,2.0878380495944775,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOH']",0.9979240165281176,0,0,6
37,Non-small cell lung cancer WP4255,0.25801498060448247,1.868020304568528,2.5306774027953534,"['CYCS', 'BAX', 'HRAS']",0.9979240165281176,0,0,3
38,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.28586556114821016,1.5732381801962534,1.9700617802004072,"['AXL', 'RPS6', 'BAX', 'HRAS']",0.9979240165281176,0,0,4
39,TP53 network WP1742,0.2890241633985494,2.133687258687259,2.648428607247342,"['SUMO1', 'BAX']",0.9979240165281176,0,0,2
40,DNA Mismatch Repair WP531,0.2890241633985494,2.133687258687259,2.648428607247342,"['POLD4', 'POLE3']",0.9979240165281176,0,0,2
41,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.2890241633985494,2.133687258687259,2.648428607247342,"['MFGE8', 'HRAS']",0.9979240165281176,0,0,2
42,Histone Modifications WP2369,0.2890241633985494,2.133687258687259,2.648428607247342,"['SET', 'HIST1H3E']",0.9979240165281176,0,0,2
43,Translation Factors WP107,0.2918801973399119,1.7239359625146427,2.1228751625130413,"['EEF1B2', 'EIF3D', 'EIF1']",0.9979240165281176,0,0,3
44,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.31457778357125943,3.7318718381112985,4.315999005615889,['IDH3B'],0.9979240165281176,0,0,1
45,Benzo(a)pyrene metabolism WP696,0.31457778357125943,3.7318718381112985,4.315999005615889,['AKR1C3'],0.9979240165281176,0,0,1
46,Canonical NF-KB pathway WP4562,0.31457778357125943,3.7318718381112985,4.315999005615889,['NFKBIE'],0.9979240165281176,0,0,1
47,Glycosylation and related congenital defects WP4521,0.33506287724560346,1.866554054054054,2.04095939865906,"['DPM2', 'DPM3']",0.9979240165281176,0,0,2
48,Interferon type I signaling pathways WP585,0.33506287724560346,1.866554054054054,2.04095939865906,"['ZAP70', 'RPS6']",0.9979240165281176,0,0,2
49,MET in type 1 papillary renal cell carcinoma WP4205,0.33506287724560346,1.866554054054054,2.04095939865906,"['RPL11', 'HRAS']",0.9979240165281176,0,0,2
50,Nanomaterial induced apoptosis WP2507,0.33506287724560346,1.866554054054054,2.04095939865906,"['BAX', 'CYCS']",0.9979240165281176,0,0,2
51,Thermogenesis WP4321,0.342109324377241,1.4227602905569008,1.526088158600194,"['RPS6', 'ZNF516', 'CPT1B', 'HRAS']",0.9979240165281176,0,0,4
52,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.342109324377241,1.4227602905569008,1.526088158600194,"['POMC', 'RPS6', 'ZNF516', 'HRAS']",0.9979240165281176,0,0,4
53,VEGFA-VEGFR2 Signaling Pathway WP3888,0.34250967527305504,1.145861632863366,1.2277396029096141,"['SET', 'RPS6', 'SARS', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9979240165281176,0,0,17
54,Endometrial cancer WP4155,0.3601311404581353,1.4934010152284265,1.5251910946325147,"['BAX', 'FGF1', 'HRAS']",0.9979240165281176,0,0,3
55,Allograft Rejection WP2328,0.37040438708371387,1.3577812018489985,1.3484938862373992,"['C1QA', 'HLA-B', 'HLA-DRB1', 'C1QC']",0.9979240165281176,0,0,4
56,Ciliary landscape WP4352,0.37859329946372233,1.2160770175508102,1.1811667766738934,"['COPS6', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'COX6C', 'LSM4']",0.9979240165281176,0,0,7
57,Amyotrophic lateral sclerosis (ALS) WP2447,0.3801748569484284,1.6587837837837838,1.6042495786379949,"['BAX', 'NEFH']",0.9979240165281176,0,0,2
58,Interleukin-11 Signaling Pathway WP2332,0.3801748569484284,1.6587837837837838,1.6042495786379949,"['RPS6', 'HRAS']",0.9979240165281176,0,0,2
59,IL-18 signaling pathway WP4754,0.39211359167543963,1.1415094339622642,1.068685363064213,"['NRN1', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'BPGM', 'RPS11', 'NFKBIE', 'RND2', 'ABCF1']",0.9979240165281176,0,0,11
60,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.393979744441312,1.399746192893401,1.303801683377733,"['APEX1', 'RPS6', 'HRAS']",0.9979240165281176,0,0,3
61,Leptin signaling pathway WP2034,0.393979744441312,1.399746192893401,1.303801683377733,"['RPS6', 'BAX', 'HRAS']",0.9979240165281176,0,0,3
62,Serotonin and anxiety-related events WP3944,0.39569756903363545,2.4873524451939293,2.3060370729340307,['CRH'],0.9979240165281176,0,0,1
63,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.39569756903363545,2.4873524451939293,2.3060370729340307,['DLL3'],0.9979240165281176,0,0,1
64,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.39569756903363545,2.4873524451939293,2.3060370729340307,['COX8A'],0.9979240165281176,0,0,1
65,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.39569756903363545,2.4873524451939293,2.3060370729340307,['HIST1H3E'],0.9979240165281176,0,0,1
66,Glutathione metabolism WP100,0.39569756903363545,2.4873524451939293,2.3060370729340307,['GPX4'],0.9979240165281176,0,0,1
67,Homologous recombination WP186,0.39569756903363545,2.4873524451939293,2.3060370729340307,['POLD4'],0.9979240165281176,0,0,1
68,Macrophage markers WP4146,0.39569756903363545,2.4873524451939293,2.3060370729340307,['CD74'],0.9979240165281176,0,0,1
69,MTHFR deficiency WP4288,0.39569756903363545,2.4873524451939293,2.3060370729340307,['CYCS'],0.9979240165281176,0,0,1
70,Type 2 papillary renal cell carcinoma WP4241,0.42393554749738266,1.4925675675675676,1.2808824497614042,"['ELOB', 'ELOC']",0.9979240165281176,0,0,2
71,Copper homeostasis WP3286,0.42393554749738266,1.4925675675675676,1.2808824497614042,"['COX17', 'ATOX1']",0.9979240165281176,0,0,2
72,IL-2 signaling pathway WP49,0.42393554749738266,1.4925675675675676,1.2808824497614042,"['RPS6', 'HRAS']",0.9979240165281176,0,0,2
73,Parkinson's disease pathway WP2371,0.42393554749738266,1.4925675675675676,1.2808824497614042,"['CYCS', 'PARK7']",0.9979240165281176,0,0,2
74,TNF-alpha signaling pathway WP231,0.4542400647937799,1.1940338983050847,0.942247305827317,"['BAX', 'TXN', 'NFKBIE', 'HRAS']",0.9979240165281176,0,0,4
75,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.46723105547039745,1.8650927487352444,1.4192075957810009,['HRAS'],0.9979240165281176,0,0,1
76,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.46723105547039745,1.8650927487352444,1.4192075957810009,['NFKBIE'],0.9979240165281176,0,0,1
77,Cancer immunotherapy by CTLA4 blockade WP4582,0.46723105547039745,1.8650927487352444,1.4192075957810009,['HLA-DRB1'],0.9979240165281176,0,0,1
78,Type II diabetes mellitus WP1584,0.46723105547039745,1.8650927487352444,1.4192075957810009,['SURF1'],0.9979240165281176,0,0,1
79,Fatty Acid Biosynthesis WP357,0.46723105547039745,1.8650927487352444,1.4192075957810009,['ECHDC3'],0.9979240165281176,0,0,1
80,Fatty acid transporters WP5061,0.46723105547039745,1.8650927487352444,1.4192075957810009,['FABP6'],0.9979240165281176,0,0,1
81,Genes targeted by miRNAs in adipocytes WP1992,0.46723105547039745,1.8650927487352444,1.4192075957810009,['TMSB4X'],0.9979240165281176,0,0,1
82,"GPCRs, Class B Secretin-like WP334",0.46723105547039745,1.8650927487352444,1.4192075957810009,['ADGRL2'],0.9979240165281176,0,0,1
83,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.46723105547039745,1.8650927487352444,1.4192075957810009,['HRAS'],0.9979240165281176,0,0,1
84,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.46723105547039745,1.8650927487352444,1.4192075957810009,['VEGFB'],0.9979240165281176,0,0,1
85,Purine metabolism and related disorders WP4224,0.46723105547039745,1.8650927487352444,1.4192075957810009,['APRT'],0.9979240165281176,0,0,1
86,RalA downstream regulated genes WP2290,0.46723105547039745,1.8650927487352444,1.4192075957810009,['HRAS'],0.9979240165281176,0,0,1
87,Prolactin Signaling Pathway WP2037,0.49189080880477853,1.1779321399946567,0.8357411105099901,"['ZAP70', 'RPS6', 'HRAS']",0.9979240165281176,0,0,3
88,Lung fibrosis WP3624,0.5062495001036788,1.2432432432432432,0.8463075623925502,"['DSP', 'FGF1']",0.9979240165281176,0,0,2
89,Microglia Pathogen Phagocytosis Pathway WP3937,0.5062495001036788,1.2432432432432432,0.8463075623925502,"['C1QA', 'C1QC']",0.9979240165281176,0,0,2
90,Acute viral myocarditis WP4298,0.5227945797022518,1.1187817258883248,0.725604532943828,"['CYCS', 'BAX', 'AIF1']",0.9979240165281176,0,0,3
91,Apoptosis Modulation by HSP70 WP384,0.5303094130119477,1.4917369308600337,0.9462007464622805,['CYCS'],0.9979240165281176,0,0,1
92,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5303094130119477,1.4917369308600337,0.9462007464622805,['HSD11B2'],0.9979240165281176,0,0,1
93,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5303094130119477,1.4917369308600337,0.9462007464622805,['BAX'],0.9979240165281176,0,0,1
94,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5303094130119477,1.4917369308600337,0.9462007464622805,['SPARC'],0.9979240165281176,0,0,1
95,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5303094130119477,1.4917369308600337,0.9462007464622805,['BAX'],0.9979240165281176,0,0,1
96,Nanoparticle-mediated activation of receptor signaling WP2643,0.5303094130119477,1.4917369308600337,0.9462007464622805,['HRAS'],0.9979240165281176,0,0,1
97,Nucleotide metabolism WP404,0.5303094130119477,1.4917369308600337,0.9462007464622805,['NME2'],0.9979240165281176,0,0,1
98,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5303094130119477,1.4917369308600337,0.9462007464622805,['ANAPC11'],0.9979240165281176,0,0,1
99,Kit receptor signaling pathway WP304,0.5444394036312159,1.1473492723492724,0.6975867867513699,"['RPS6', 'HRAS']",0.9979240165281176,0,0,2
100,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5444394036312159,1.1473492723492724,0.6975867867513699,"['NDUFA13', 'COPS6']",0.9979240165281176,0,0,2
101,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5526400513029553,1.0652646845540246,0.6317535073676965,"['PSMC5', 'PSMD7', 'PSMC1']",0.9979240165281176,0,0,3
102,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5805192658883439,1.0651544401544402,0.579265378346809,"['IFI27L2', 'HRAS']",0.9979240165281176,0,0,2
103,Apoptosis WP254,0.581348768067618,1.01661282879557,0.5514152846091964,"['CYCS', 'BAX', 'NFKBIE']",0.9979240165281176,0,0,3
104,Ebola Virus Pathway on Host WP4217,0.583916433434829,0.9938983050847457,0.5347147038273241,"['AXL', 'HLA-B', 'MFGE8', 'HLA-DRB1']",0.9979240165281176,0,0,4
105,Airway smooth muscle cell contraction WP4962,0.5859305349438236,1.2428330522765598,0.6643614260119614,['PPP1R14A'],0.9979240165281176,0,0,1
106,BDNF-TrkB Signaling WP3676,0.5859305349438236,1.2428330522765598,0.6643614260119614,['HRAS'],0.9979240165281176,0,0,1
107,Cytokines and Inflammatory Response WP530,0.5859305349438236,1.2428330522765598,0.6643614260119614,['HLA-DRB1'],0.9979240165281176,0,0,1
108,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.5859305349438236,1.2428330522765598,0.6643614260119614,['TBXAS1'],0.9979240165281176,0,0,1
109,ERK Pathway in Huntington's Disease WP3853,0.5859305349438236,1.2428330522765598,0.6643614260119614,['HRAS'],0.9979240165281176,0,0,1
110,Fatty acid beta-oxidation WP143,0.5859305349438236,1.2428330522765598,0.6643614260119614,['CPT1B'],0.9979240165281176,0,0,1
111,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5859305349438236,1.2428330522765598,0.6643614260119614,['RPS6'],0.9979240165281176,0,0,1
112,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5859305349438236,1.2428330522765598,0.6643614260119614,['RPS6'],0.9979240165281176,0,0,1
113,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5859305349438236,1.2428330522765598,0.6643614260119614,['SUPT4H1'],0.9979240165281176,0,0,1
114,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5859305349438236,1.2428330522765598,0.6643614260119614,['BAX'],0.9979240165281176,0,0,1
115,Matrix Metalloproteinases WP129,0.5859305349438236,1.2428330522765598,0.6643614260119614,['MMP26'],0.9979240165281176,0,0,1
116,Methionine De Novo and Salvage Pathway WP3580,0.5859305349438236,1.2428330522765598,0.6643614260119614,['TXN'],0.9979240165281176,0,0,1
117,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.5859305349438236,1.2428330522765598,0.6643614260119614,['SOX6'],0.9979240165281176,0,0,1
118,PDGFR-beta pathway WP3972,0.5859305349438236,1.2428330522765598,0.6643614260119614,['HRAS'],0.9979240165281176,0,0,1
119,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5859305349438236,1.2428330522765598,0.6643614260119614,['BAX'],0.9979240165281176,0,0,1
120,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5859305349438236,1.2428330522765598,0.6643614260119614,['HRAS'],0.9979240165281176,0,0,1
121,Androgen receptor signaling pathway WP138,0.6088632327175623,0.9721915691900243,0.4823641374174943,"['SUMO1', 'BAG1', 'PARK7']",0.9979240165281176,0,0,3
122,Corticotropin-releasing hormone signaling pathway WP2355,0.6088632327175623,0.9721915691900243,0.4823641374174943,"['POMC', 'CRHBP', 'CRH']",0.9979240165281176,0,0,3
123,Cytosolic DNA-sensing pathway WP4655,0.6144532648526018,0.9939189189189189,0.48406078406624203,"['POLR2K', 'POLR2L']",0.9979240165281176,0,0,2
124,Ferroptosis WP4313,0.6144532648526018,0.9939189189189189,0.48406078406624203,"['GPX4', 'FTH1']",0.9979240165281176,0,0,2
125,PPAR signaling pathway WP3942,0.6144532648526018,0.9939189189189189,0.48406078406624203,"['FABP6', 'CPT1B']",0.9979240165281176,0,0,2
126,Biomarkers for pyrimidine metabolism disorders WP4584,0.6349747165953845,1.0650445675740785,0.48371139484919257,['NT5C'],0.9979240165281176,0,0,1
127,Eicosanoid Synthesis WP167,0.6349747165953845,1.0650445675740785,0.48371139484919257,['TBXAS1'],0.9979240165281176,0,0,1
128,MAPK Cascade WP422,0.6349747165953845,1.0650445675740785,0.48371139484919257,['HRAS'],0.9979240165281176,0,0,1
129,Overview of nanoparticle effects WP3287,0.6349747165953845,1.0650445675740785,0.48371139484919257,['BAX'],0.9979240165281176,0,0,1
130,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6349747165953845,1.0650445675740785,0.48371139484919257,['HRAS'],0.9979240165281176,0,0,1
131,Pyrimidine metabolism and related diseases WP4225,0.6349747165953845,1.0650445675740785,0.48371139484919257,['NT5C'],0.9979240165281176,0,0,1
132,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6349747165953845,1.0650445675740785,0.48371139484919257,['BAX'],0.9979240165281176,0,0,1
133,Sleep regulation WP3591,0.6462435031808738,0.9315878378378378,0.4067115993796565,"['CRH', 'HCRTR1']",0.9979240165281176,0,0,2
134,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6486527529947423,0.9083191850594228,0.39317300307090663,"['DSP', 'SPARC', 'GDF15', 'HRAS', 'DLL3']",0.9979240165281176,0,0,5
135,22q11.2 copy number variation syndrome WP4657,0.6601699845834187,0.894010152284264,0.37124480051927866,"['RANBP1', 'MRPL40', 'EMC10']",0.9979240165281176,0,0,3
136,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6601699845834187,0.894010152284264,0.37124480051927866,"['CTSV', 'SOX6', 'SLC38A2']",0.9979240165281176,0,0,3
137,Endochondral Ossification WP474,0.6601699845834187,0.894010152284264,0.37124480051927866,"['CTSV', 'SOX6', 'SLC38A2']",0.9979240165281176,0,0,3
138,Genotoxicity pathway WP4286,0.6759215641854864,0.8765898251192369,0.34334115901268464,"['RPS27', 'TRIAP1']",0.9979240165281176,0,0,2
139,Integrin-mediated Cell Adhesion WP185,0.6759215641854864,0.8765898251192369,0.34334115901268464,"['ITGA8', 'HRAS']",0.9979240165281176,0,0,2
140,p53 transcriptional gene network WP4963,0.6759215641854864,0.8765898251192369,0.34334115901268464,"['SIVA1', 'BAX']",0.9979240165281176,0,0,2
141,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6782184930688258,0.9317032040472175,0.36176710698275655,['HRAS'],0.9979240165281176,0,0,1
142,Alpha 6 Beta 4 signaling pathway WP244,0.6782184930688258,0.9317032040472175,0.36176710698275655,['HRAS'],0.9979240165281176,0,0,1
143,Statin inhibition of cholesterol production WP430,0.6782184930688258,0.9317032040472175,0.36176710698275655,['APOC1'],0.9979240165281176,0,0,1
144,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6782184930688258,0.9317032040472175,0.36176710698275655,['ZAP70'],0.9979240165281176,0,0,1
145,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6782184930688258,0.9317032040472175,0.36176710698275655,['HRAS'],0.9979240165281176,0,0,1
146,Galanin receptor pathway WP4970,0.6782184930688258,0.9317032040472175,0.36176710698275655,['POMC'],0.9979240165281176,0,0,1
147,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6782184930688258,0.9317032040472175,0.36176710698275655,['FGF1'],0.9979240165281176,0,0,1
148,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.703541528880635,0.8277027027027027,0.2910437541466201,"['CYCS', 'BAX']",0.9979240165281176,0,0,2
149,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7163468511223409,0.8279932546374368,0.276210932521669,['HRAS'],0.9979240165281176,0,0,1
150,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7163468511223409,0.8279932546374368,0.276210932521669,['RPS6'],0.9979240165281176,0,0,1
151,One-carbon metabolism and related pathways WP3940,0.7163468511223409,0.8279932546374368,0.276210932521669,['GPX4'],0.9979240165281176,0,0,1
152,7q11.23 copy number variation syndrome WP4932,0.7276849306563236,0.7976794778825236,0.25357202554569497,"['ATP5MC2', 'ATP5F1E', 'ATP5MC1']",0.9979240165281176,0,0,3
153,Complement system WP2806,0.7276849306563236,0.7976794778825236,0.25357202554569497,"['FCGR3A', 'RPS19', 'TXN']",0.9979240165281176,0,0,3
154,Oncostatin M Signaling Pathway WP2374,0.7291742289011456,0.7839615931721194,0.24760845096019102,"['RPS6', 'HRAS']",0.9979240165281176,0,0,2
155,7-oxo-C and 7beta-HC pathways WP5064,0.7499640061406914,0.7450252951096121,0.21436617689834148,['HSD11B2'],0.9979240165281176,0,0,1
156,Canonical and non-canonical Notch signaling WP3845,0.7499640061406914,0.7450252951096121,0.21436617689834148,['DLL3'],0.9979240165281176,0,0,1
157,Type II interferon signaling (IFNG) WP619,0.7499640061406914,0.7450252951096121,0.21436617689834148,['HLA-B'],0.9979240165281176,0,0,1
158,Imatinib and Chronic Myeloid Leukemia WP3640,0.7499640061406914,0.7450252951096121,0.21436617689834148,['SKP2'],0.9979240165281176,0,0,1
159,Inflammatory Response Pathway WP453,0.7499640061406914,0.7450252951096121,0.21436617689834148,['ZAP70'],0.9979240165281176,0,0,1
160,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7499640061406914,0.7450252951096121,0.21436617689834148,['HRAS'],0.9979240165281176,0,0,1
161,Notch Signaling WP268,0.7499640061406914,0.7450252951096121,0.21436617689834148,['DLL3'],0.9979240165281176,0,0,1
162,p38 MAPK Signaling Pathway WP400,0.7499640061406914,0.7450252951096121,0.21436617689834148,['HRAS'],0.9979240165281176,0,0,1
163,PDGF Pathway WP2526,0.7499640061406914,0.7450252951096121,0.21436617689834148,['HRAS'],0.9979240165281176,0,0,1
164,Pregnane X receptor pathway WP2876,0.7499640061406914,0.7450252951096121,0.21436617689834148,['PSMC5'],0.9979240165281176,0,0,1
165,Regulation of Microtubule Cytoskeleton WP2038,0.7499640061406914,0.7450252951096121,0.21436617689834148,['PARD6A'],0.9979240165281176,0,0,1
166,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7529025402337254,0.7445945945945946,0.21133045675382076,"['DSP', 'ITGA8']",0.9979240165281176,0,0,2
167,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7529025402337254,0.7445945945945946,0.21133045675382076,"['TMSB4X', 'NEFH']",0.9979240165281176,0,0,2
168,Glucocorticoid Receptor Pathway WP2880,0.7529025402337254,0.7445945945945946,0.21133045675382076,"['SRGN', 'MFGE8']",0.9979240165281176,0,0,2
169,Hippo-Merlin Signaling Dysregulation WP4541,0.7665477928264403,0.7441624365482233,0.19784170865226658,"['PPP1R14A', 'ITGA8', 'HRAS']",0.9979240165281176,0,0,3
170,Head and Neck Squamous Cell Carcinoma WP4674,0.7748175527856365,0.708976833976834,0.18087962411661565,"['RPS6', 'HRAS']",0.9979240165281176,0,0,2
171,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7748175527856365,0.708976833976834,0.18087962411661565,"['BAX', 'HRAS']",0.9979240165281176,0,0,2
172,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7796029119156069,0.6771424191323011,0.16858853827106465,['RPS6'],0.9979240165281176,0,0,1
173,CAMKK2  Pathway WP4874,0.7796029119156069,0.6771424191323011,0.16858853827106465,['FIS1'],0.9979240165281176,0,0,1
174,Vitamin D-sensitive calcium signaling in depression WP4698,0.7796029119156069,0.6771424191323011,0.16858853827106465,['GPX4'],0.9979240165281176,0,0,1
175,Genes controlling nephrogenesis WP4823,0.7796029119156069,0.6771424191323011,0.16858853827106465,['ITGA8'],0.9979240165281176,0,0,1
176,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7796029119156069,0.6771424191323011,0.16858853827106465,['CYCS'],0.9979240165281176,0,0,1
177,T-cell receptor (TCR) signaling pathway WP69,0.7950154757550645,0.6765970515970516,0.15520709982912084,"['ZAP70', 'HRAS']",0.9979240165281176,0,0,2
178,DNA damage response WP707,0.7950154757550645,0.6765970515970516,0.15520709982912084,"['CYCS', 'BAX']",0.9979240165281176,0,0,2
179,Melanoma WP4685,0.7950154757550645,0.6765970515970516,0.15520709982912084,"['BAX', 'HRAS']",0.9979240165281176,0,0,2
180,Spinal Cord Injury WP2431,0.7963518999789865,0.7254237288135593,0.16518921546300724,"['BCAN', 'APEX1', 'LILRB3', 'AIF1']",0.9979240165281176,0,0,4
181,Regulation of Actin Cytoskeleton WP51,0.8007753980752745,0.6973350253807107,0.15493025106463143,"['TMSB4X', 'BRK1', 'FGF1']",0.9979240165281176,0,0,3
182,Endothelin Pathways WP2197,0.8057336531141074,0.6205733558178752,0.13404511472429756,['RIIAD1'],0.9979240165281176,0,0,1
183,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8057336531141074,0.6205733558178752,0.13404511472429756,['CYCS'],0.9979240165281176,0,0,1
184,Integrated Cancer Pathway WP1971,0.8057336531141074,0.6205733558178752,0.13404511472429756,['BAX'],0.9979240165281176,0,0,1
185,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8057336531141074,0.6205733558178752,0.13404511472429756,['BAX'],0.9979240165281176,0,0,1
186,Breast cancer pathway WP4262,0.8104184638929954,0.7079903147699758,0.14882278030183066,"['BAX', 'FGF1', 'HRAS', 'DLL3']",0.9979240165281176,0,0,4
187,ESC Pluripotency Pathways WP3931,0.8135951573989381,0.6470329024676851,0.13347796148518645,"['FGF1', 'HRAS']",0.9979240165281176,0,0,2
188,miRNA regulation of DNA damage response WP1530,0.8135951573989381,0.6470329024676851,0.13347796148518645,"['CYCS', 'BAX']",0.9979240165281176,0,0,2
189,Hepatitis B infection WP4666,0.8162516405611144,0.6760498384863867,0.13726014867488098,"['CYCS', 'BAX', 'HRAS']",0.9979240165281176,0,0,3
190,TGF-beta Receptor Signaling WP560,0.8287708500725353,0.5727072253210533,0.10756104848695856,['HRAS'],0.9979240165281176,0,0,1
191,Bladder cancer WP2828,0.8287708500725353,0.5727072253210533,0.10756104848695856,['HRAS'],0.9979240165281176,0,0,1
192,DNA Replication WP466,0.8287708500725353,0.5727072253210533,0.10756104848695856,['POLD4'],0.9979240165281176,0,0,1
193,Heart Development WP1591,0.8287708500725353,0.5727072253210533,0.10756104848695856,['VEGFB'],0.9979240165281176,0,0,1
194,IL-5 signaling pathway WP127,0.8287708500725353,0.5727072253210533,0.10756104848695856,['RPS6'],0.9979240165281176,0,0,1
195,MECP2 and Associated Rett Syndrome WP3584,0.8287708500725353,0.5727072253210533,0.10756104848695856,['RPS6'],0.9979240165281176,0,0,1
196,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8287708500725353,0.5727072253210533,0.10756104848695856,['BAX'],0.9979240165281176,0,0,1
197,Complement and Coagulation Cascades WP558,0.8306561187777175,0.6199324324324325,0.11502188282800023,"['C1QA', 'C1QC']",0.9979240165281176,0,0,2
198,Neural Crest Differentiation WP2064,0.8306561187777175,0.6199324324324325,0.11502188282800023,"['PRTG', 'DLL3']",0.9979240165281176,0,0,2
199,Retinoblastoma gene in cancer WP2446,0.8306561187777175,0.6199324324324325,0.11502188282800023,"['H2AFZ', 'SKP2']",0.9979240165281176,0,0,2
200,Aryl Hydrocarbon Receptor Pathway WP2873,0.8490801933898421,0.5316791134666345,0.08698357536452808,['BAX'],0.9979240165281176,0,0,1
201,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8490801933898421,0.5316791134666345,0.08698357536452808,['HRAS'],0.9979240165281176,0,0,1
202,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8490801933898421,0.5316791134666345,0.08698357536452808,['BAX'],0.9979240165281176,0,0,1
203,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8490801933898421,0.5316791134666345,0.08698357536452808,['PPP1R14A'],0.9979240165281176,0,0,1
204,IL-3 signaling pathway WP286,0.8490801933898421,0.5316791134666345,0.08698357536452808,['HRAS'],0.9979240165281176,0,0,1
205,Nephrotic syndrome WP4758,0.8490801933898421,0.5316791134666345,0.08698357536452808,['EMP2'],0.9979240165281176,0,0,1
206,EGF/EGFR signaling pathway WP437,0.8566776827907056,0.6192893401015228,0.0958000544553187,"['NDUFA13', 'NEDD8', 'HRAS']",0.9979240165281176,0,0,3
207,Small cell lung cancer WP4658,0.860614445404471,0.571985446985447,0.08585997667810079,"['CYCS', 'BAX']",0.9979240165281176,0,0,2
208,DNA damage response (only ATM dependent) WP710,0.860614445404471,0.571985446985447,0.08585997667810079,"['BAX', 'HRAS']",0.9979240165281176,0,0,2
209,Aryl Hydrocarbon Receptor Netpath WP2586,0.8669842096205846,0.4961214165261383,0.07081364978441723,['HRAS'],0.9979240165281176,0,0,1
210,Development of ureteric collection system WP5053,0.8669842096205846,0.4961214165261383,0.07081364978441723,['ITGA8'],0.9979240165281176,0,0,1
211,Alzheimer's disease WP2059,0.8737020675145333,0.5506756756756757,0.0743499418327405,"['ATP5MD', 'CYCS']",0.9979240165281176,0,0,2
212,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8827673482388526,0.46500843170320405,0.05798357160030539,['RNF7'],0.9979240165281176,0,0,1
213,Notch Signaling Pathway Netpath WP61,0.8827673482388526,0.46500843170320405,0.05798357160030539,['DLL3'],0.9979240165281176,0,0,1
214,Pathways affected in adenoid cystic carcinoma WP3651,0.8827673482388526,0.46500843170320405,0.05798357160030539,['HRAS'],0.9979240165281176,0,0,1
215,Metapathway biotransformation Phase I and II WP702,0.8891055022058245,0.5712612260835611,0.06714568768262709,"['GPX4', 'GSTO1', 'AKR1C3']",0.9979240165281176,0,0,3
216,AGE/RAGE pathway WP2324,0.8966804703724677,0.43755579803590916,0.04771795415252508,['CYCS'],0.9979240165281176,0,0,1
217,AMP-activated protein kinase (AMPK) signaling WP1403,0.8966804703724677,0.43755579803590916,0.04771795415252508,['CPT1B'],0.9979240165281176,0,0,1
218,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8966804703724677,0.43755579803590916,0.04771795415252508,['HRAS'],0.9979240165281176,0,0,1
219,Synaptic Vesicle Pathway WP2267,0.8966804703724677,0.43755579803590916,0.04771795415252508,['PARK7'],0.9979240165281176,0,0,1
220,ErbB signaling pathway WP673,0.8966804703724677,0.43755579803590916,0.04771795415252508,['HRAS'],0.9979240165281176,0,0,1
221,Glioblastoma signaling pathways WP2261,0.8966804703724677,0.43755579803590916,0.04771795415252508,['HRAS'],0.9979240165281176,0,0,1
222,Apoptosis Modulation and Signaling WP1772,0.9064660180107812,0.49527027027027026,0.04863640058531528,"['CYCS', 'BAX']",0.9979240165281176,0,0,2
223,NRF2 pathway WP2884,0.9069137779096546,0.5431472081218274,0.05306977110305302,"['FTH1', 'TXN', 'SLC5A3']",0.9979240165281176,0,0,3
224,TYROBP causal network in microglia WP3945,0.9089448092844529,0.4131534569983137,0.03944413341336245,['C1QC'],0.9979240165281176,0,0,1
225,Differentiation Pathway WP2848,0.9089448092844529,0.4131534569983137,0.03944413341336245,['FGF1'],0.9979240165281176,0,0,1
226,Folate Metabolism WP176,0.9089448092844529,0.4131534569983137,0.03944413341336245,['GPX4'],0.9979240165281176,0,0,1
227,Myometrial relaxation and contraction pathways WP289,0.9116899940636952,0.5705345501955671,0.05274892330561257,"['GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9979240165281176,0,0,4
228,TGF-beta Signaling Pathway WP366,0.9154929681795679,0.4791848299912816,0.04230847248372985,"['PARD6A', 'SUMO1']",0.9979240165281176,0,0,2
229,16p11.2 proximal deletion syndrome WP4949,0.9197554639455072,0.3913197834383598,0.03273289980014481,['SEZ6L2'],0.9979240165281176,0,0,1
230,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9197554639455072,0.3913197834383598,0.03273289980014481,['ZAP70'],0.9979240165281176,0,0,1
231,G Protein Signaling Pathways WP35,0.9197554639455072,0.3913197834383598,0.03273289980014481,['HRAS'],0.9979240165281176,0,0,1
232,Vitamin D Receptor Pathway WP2877,0.9249031489004064,0.5491525423728814,0.04287028012395228,"['COLEC11', 'S100A6', 'S100A8', 'HLA-DRB1']",0.9979240165281176,0,0,4
233,Pancreatic adenocarcinoma pathway WP4263,0.9376835789648899,0.3538906287641532,0.02277028660854722,['BAX'],0.9979240165281176,0,0,1
234,Prader-Willi and Angelman Syndrome WP3998,0.9376835789648899,0.3538906287641532,0.02277028660854722,['POMC'],0.9979240165281176,0,0,1
235,Senescence and Autophagy in Cancer WP615,0.9379057014888188,0.43660572337042924,0.02798898821174496,"['SPARC', 'HRAS']",0.9979240165281176,0,0,2
236,Osteoblast differentiation WP4787,0.9379057014888188,0.43660572337042924,0.02798898821174496,"['FGF1', 'DLL3']",0.9979240165281176,0,0,2
237,Nuclear Receptors Meta-Pathway WP2882,0.9437717159137158,0.5881214186154561,0.034035156057897496,"['SRGN', 'PSMC5', 'FTH1', 'BAX', 'TXN', 'MFGE8', 'SLC5A3']",0.9979240165281176,0,0,7
238,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9495806183841341,0.41216216216216217,0.02132314606467012,"['RPS6', 'HRAS']",0.9979240165281176,0,0,2
239,Integrated breast cancer pathway WP1984,0.9495806183841341,0.41216216216216217,0.02132314606467012,"['BAX', 'FAU']",0.9979240165281176,0,0,2
240,Circadian rhythm related genes WP3594,0.9504973729890202,0.5020396437805228,0.025488492910542792,"['CAVIN3', 'CRH', 'RPS27A', 'HCRTR1']",0.9979240165281176,0,0,4
241,Exercise-induced Circadian Regulation WP410,0.9516113247787654,0.3229708922941565,0.016018904049387307,['SUMO1'],0.9979240165281176,0,0,1
242,Peptide GPCRs WP24,0.9516113247787654,0.3229708922941565,0.016018904049387307,['HCRTR1'],0.9979240165281176,0,0,1
243,Cell cycle WP179,0.9546023686451275,0.40093133674214754,0.01862742751814691,"['SKP2', 'ANAPC11']",0.9979240165281176,0,0,2
244,Gastrin signaling pathway WP4659,0.9546023686451275,0.40093133674214754,0.01862742751814691,"['RPS6', 'HRAS']",0.9979240165281176,0,0,2
245,B Cell Receptor Signaling Pathway WP23,0.9573619575226461,0.3094435075885329,0.01348361032853561,['HRAS'],0.9979240165281176,0,0,1
246,Endoderm differentiation WP2853,0.9668967707562685,0.28551044234012196,0.009611292564162939,['NME1'],0.9979240165281176,0,0,1
247,Focal Adhesion WP306,0.9692130309413753,0.4190211665549277,0.013103145985111916,"['VEGFB', 'ITGA8', 'HRAS']",0.9979240165281176,0,0,3
248,Ras signaling WP4223,0.9703017234989338,0.3614864864864865,0.01089816714449613,"['ZAP70', 'HRAS']",0.9979240165281176,0,0,2
249,Chemokine signaling pathway WP3929,0.9800527708801883,0.2472175379426644,0.004981151791546652,['HRAS'],0.9979240165281176,0,0,1
250,Mesodermal commitment pathway WP2857,0.9800527708801883,0.2472175379426644,0.004981151791546652,['RPL38'],0.9979240165281176,0,0,1
251,Ectoderm Differentiation WP2858,0.9824265019845183,0.23918838056900396,0.0042407490368723665,['PLCXD3'],0.9979240165281176,0,0,1
252,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9850062398488462,0.4390007276255154,0.006632116991103785,"['RPS6', 'VEGFB', 'ITGA8', 'FGF1', 'HRAS']",0.9979240165281176,0,0,5
253,"GPCRs, Class A Rhodopsin-like WP455",0.9856893517804437,0.4044578592988159,0.005829868958235414,"['NPFFR1', 'GPR35', 'APLNR', 'HCRTR1']",0.9979240165281176,0,0,4
254,PI3K-Akt signaling pathway WP4172,0.9860855097713994,0.4604591836734694,0.0064520481229235266,"['RPS6', 'VEGFB', 'ITGA8', 'COL9A3', 'FGF1', 'HRAS']",0.9979240165281176,0,0,6
255,Insulin Signaling WP481,0.9863611603542607,0.22458991261689407,0.0030842265791100687,['HRAS'],0.9979240165281176,0,0,1
256,"GPCRs, Other WP117",0.9894158756714093,0.21165984100216814,0.0022521738533240214,['ADGRL2'],0.9979240165281176,0,0,1
257,Calcium Regulation in the Cardiac Cell WP536,0.9899988197694044,0.2899443561208267,0.0029143838158254666,"['GJD2', 'RGS6']",0.9979240165281176,0,0,2
258,Ciliopathies WP4803,0.990676509288734,0.2057335581787521,0.0019271528401548013,['CCDC28B'],0.9979240165281176,0,0,1
259,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9966221099124489,0.1680208493024682,0.000568516696303525,['CDCA7L'],0.9979240165281176,0,0,1
260,MAPK Signaling Pathway WP382,0.9979240165281176,0.22676715176715176,0.0004712541864086928,"['FGF1', 'HRAS']",0.9979240165281176,0,0,2
